---All---
  • ---All---
  • Accession
  • Catalog #

PDGFRA predesign siRNASynthetic RNA

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
RI13882 5 OD 400 ul 13-15 days $ 110.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

PDGFRA predesign siRNA - Additional info

Gene ID5156
Gene SymbolPDGFRA
Other Names
CD140A, PDGFR2, MGC74795, RHEPDGFRA, PDGFRA
Format
HPLC purified siRNA is supplied as a dried pellet in nmol quantities.
Storage
Maintain refrigerated at 2-8°C for up to one week. For long term storage store at -20°C.
Precautions
This product is for research use only. Not for use in diagnostic or therapeutic procedures.

PDGFRA predesign siRNA - Related products

AP3329a: Phospho-PDGFRA-Y574 Antibody

AP3330a: Phospho-PDGFRA-Y762 Antibody

AP3331a: Phospho-PDGFRA-Y1018 Antibody

AP3410a: Phospho-PDGFRA-pY754 Antibody

AP3412a: Phospho-PDGFRA-pY988 Antibody

AP3506a: Phospho-PDGFRA-pY572 Antibody

AP7666b: PDGFRA Antibody (C-term E1063)

AP7666d: PDGFRA Antibody (Y720)

AP7666f: PDGFRA Antibody (Y762)

AP7666g: PDGFRA Antibody (S767)

AP7666h: PDGFRA Antibody (Y768)

AP7666i: PDGFRA Antibody (Y574)

AP7666j: PDGFRA Antibody (Y754)

AP7666k: PDGFRA Antibody (Y988)

AP7666l: PDGFRA Antibody (Y1018)

AP7666m: PDGFRA Antibody (Y572)

AP7666n: PDGFRA Antibody

RI13882: PDGFRA predesign siRNA

DC04038: Human PDGFRA cDNA Clone

LY10723a: PDGFRA Over-expression Lysate

BP3329a: Phospho-PDGFRA-Y574 Antibody Blocking Peptide

BP3330a: Phospho-PDGFRA-Y762 Antibody Blocking Peptide

BP3331a: Phospho-PDGFRA-Y1018 Antibody Blocking Peptide

BP3410a: Phospho-PDGFRA-pY754 Antibody Blocking Peptide

BP3412a: Phospho-PDGFRA-pY988 Antibody Blocking Peptide

BP3506a: Phospho-PDGFRA-pY572 Antibody Blocking Peptide

BP7666b: PDGFRA Antibody (C-term E1063) Blocking Peptide

BP7666d: PDGFRA Antibody (Y720) Blocking Peptide

BP7666f: PDGFRA Antibody (Y762) Blocking Peptide

BP7666g: PDGFRA Antibody (S767) Blocking Peptide

BP7666h: PDGFRA Antibody (Y768) Blocking Peptide

BP7666i: PDGFRA Antibody (Y574) Blocking Peptide

BP7666j: PDGFRA Antibody (Y754) Blocking Peptide

BP7666k: PDGFRA Antibody (Y988) Blocking Peptide

BP7666l: PDGFRA Antibody (Y1018) Blocking Peptide

BP7666n: PDGFRA Antibody Blocking Peptide

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

This gene encodes a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. These growth factors are mitogens for cells of mesenchymal origin. The identity of the growth factor bound to a receptor monomer determines whether the functional receptor is a homodimer or a heterodimer, composed of both platelet-derived growth factor receptor alpha and beta polypeptides. Studies in knockout mice, where homozygosity is lethal, indicate that the alpha form of the platelet-derived growth factor receptor is particularly important for kidney development since mice heterozygous for the receptor exhibit defective kidney phenotypes.

REFERENCES

Pitfalls in mutational testing and reporting of common KIT and PDGFRA mutations in gastrointestinal stromal tumors. Merkelbach-Bruse S, et al. BMC Med Genet, 2010 Jul 4. PMID 20598160. Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. Paugh BS, et al. J Clin Oncol, 2010 Jun 20. PMID 20479398. Chromosome copy number changes carry prognostic information independent of KIT/PDGFRA point mutations in gastrointestinal stromal tumors. Silva M, et al. BMC Med, 2010 May 14. PMID 20470368. A Large-scale genetic association study of esophageal adenocarcinoma risk. Liu CY, et al. Carcinogenesis, 2010 Jul. PMID 20453000. The alpha-receptor for platelet-derived growth factor confers bone-metastatic potential to prostate cancer cells by ligand- and dimerization-independent mechanisms. Russell MR, et al. Cancer Res, 2010 May 15. PMID 20442296.